Glenn W Laub
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$2.1MFederal grants as PI3 awards
6Patents grantedLatest Nov 25, 2025
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $2.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 25, 2020 | NIH | SBIR Phase II An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion. | $960K | TDL INNOVATIONS LLC |
| Mar 6, 2019 | NIH | SBIR Phase II An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion. | $930K | TDL INNOVATIONS LLC |
| Aug 23, 2017 | NIH | SBIR Phase I An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion | $225K | TDL INNOVATIONS LLC |
7 patents as inventor
- US 10111834TDL INNOVATIONS LLCOct 30, 2018
- US 10729414TDL INNOVATIONS LLCAug 4, 2020
- US 10857100TDL INNOVATIONS LLCDec 8, 2020
- US 11684351TDL INNOVATIONS LLCJun 27, 2023
- US 12064510TDL INNOVATIONS LLCAug 20, 2024
- US 12478361TDL INNOVATIONS LLCNov 25, 2025
- US TDL INNOVATIONS LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,064
Awards as PI#927
Patents#42
Companies
- TDL INNOVATIONS LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.